212 related articles for article (PubMed ID: 32642304)
1. Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities.
Forsea AM
Dermatol Pract Concept; 2020 Jul; 10(3):e2020033. PubMed ID: 32642304
[TBL] [Abstract][Full Text] [Related]
2. Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?
Barbaric J; Sekerija M; Agius D; Coza D; Dimitrova N; Demetriou A; Safaei Diba C; Eser S; Gavric Z; Primic-Zakelj M; Zivkovic S; Zvolsky M; Bray F; Coebergh JW; Znaor A
Eur J Cancer; 2016 Mar; 55():47-55. PubMed ID: 26773419
[TBL] [Abstract][Full Text] [Related]
3. Melanoma incidence and mortality in Europe: new estimates, persistent disparities.
Forsea AM; Del Marmol V; de Vries E; Bailey EE; Geller AC
Br J Dermatol; 2012 Nov; 167(5):1124-30. PubMed ID: 22759278
[TBL] [Abstract][Full Text] [Related]
4. Melanoma prognosis in Europe: far from equal.
Forsea AM; Del Marmol V; Stratigos A; Geller AC
Br J Dermatol; 2014 Jul; 171(1):179-82. PubMed ID: 24588115
[TBL] [Abstract][Full Text] [Related]
5. Priorities and challenges for skin cancer prevention in Europe: an expert survey.
Forsea AM; Del Marmol V; Geller AC
Melanoma Res; 2013 Aug; 23(4):298-306. PubMed ID: 23777873
[TBL] [Abstract][Full Text] [Related]
6. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Kandolf Sekulovic L; Peris K; Hauschild A; Stratigos A; Grob JJ; Nathan P; Dummer R; Forsea AM; Hoeller C; Gogas H; Demidov L; Lebbe C; Blank C; Olah J; Bastholt L; Herceg D; Neyns B; Vieira R; Hansson J; Rutkowski P; Krajsova I; Bylaite-Bucinskiene M; Zalaudek I; Maric-Brozic J; Babovic N; Banjin M; Putnik K; Weinlich G; Todorovic V; Kirov K; Ocvirk J; Zhukavets A; Kukushkina M; De La Cruz Merino L; Ymeri A; Risteski M; Garbe C
Eur J Cancer; 2017 Apr; 75():313-322. PubMed ID: 28264791
[TBL] [Abstract][Full Text] [Related]
7. Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.
Vrdoljak E; Bodoky G; Jassem J; Popescu RA; Mardiak J; Pirker R; Čufer T; Bešlija S; Eniu A; Todorović V; Kubáčková K; Kurteva G; Tomašević Z; Sallaku A; Smichkoska S; Bajić Ž; Šikić BI
Oncologist; 2016 Oct; 21(10):1183-1190. PubMed ID: 27401890
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology of cutaneous melanoma: descriptive data in France and Europe].
Grange F
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):975-82. PubMed ID: 16446640
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
11. Lower incidence rates but thicker melanomas in Eastern Europe before 1992: a comparison with Western Europe.
de Vries E; Boniol M; Doré JF; Coebergh JW;
Eur J Cancer; 2004 May; 40(7):1045-52. PubMed ID: 15093581
[TBL] [Abstract][Full Text] [Related]
12. The global burden of melanoma: results from the Global Burden of Disease Study 2015.
Karimkhani C; Green AC; Nijsten T; Weinstock MA; Dellavalle RP; Naghavi M; Fitzmaurice C
Br J Dermatol; 2017 Jul; 177(1):134-140. PubMed ID: 28369739
[TBL] [Abstract][Full Text] [Related]
13. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
de Vries E; Bray FI; Coebergh JW; Parkin DM
Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
[TBL] [Abstract][Full Text] [Related]
14. 20 years of the European IVF-monitoring Consortium registry: what have we learned? A comparison with registries from two other regions.
De Geyter C; Wyns C; Calhaz-Jorge C; de Mouzon J; Ferraretti AP; Kupka M; Nyboe Andersen A; Nygren KG; Goossens V
Hum Reprod; 2020 Dec; 35(12):2832-2849. PubMed ID: 33188410
[TBL] [Abstract][Full Text] [Related]
15. EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.
Coebergh JW; van den Hurk C; Rosso S; Comber H; Storm H; Zanetti R; Sacchetto L; Janssen-Heijnen M; Thong M; Siesling S; van den Eijnden-van Raaij J
Eur J Cancer; 2015 Jun; 51(9):997-1017. PubMed ID: 25956208
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal and liver tumours and public health in Europe.
Milosavljevic T; Kostic-Milosavljevic M; Jovanovic I; Krstic M
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):259-62. PubMed ID: 20496532
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. Acute neurological stroke care in Europe: results of the European Stroke Care Inventory.
Brainin M; Bornstein N; Boysen G; Demarin V
Eur J Neurol; 2000 Jan; 7(1):5-10. PubMed ID: 10809909
[TBL] [Abstract][Full Text] [Related]
19. Estimates of cancer incidence and mortality in Europe in 1995.
Bray F; Sankila R; Ferlay J; Parkin DM
Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846
[TBL] [Abstract][Full Text] [Related]
20. Cost-of-illness of melanoma in Europe - a modelling approach.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
